Durability of Maintenance Infliximab Therapy in Children With Crohn's Disease: Are Gender and Concomitant Immunomodulators More Important Than We Thought?
Document Type
Article
Publication Date
5-2014
Repository Citation
Grossi, V.,
Lerer, T.,
Leleiko, N.,
Mack, D. R.,
Griffiths, A.,
Otley, A.,
Pfefferkorn, M.,
Rosh, J.,
Oliva-Hemker, M.,
Saeed, S. A.,
Grossman, A.,
Keljo, D.,
Sudel, B.,
Kappelman, M.,
Faubion, W.,
Schaefer, M. E.,
Tomer, G.,
Deslandres, C.,
Cabrera, J.,
Carvalho, R.,
Hitch, M. C.,
Morganstern, J.,
Kay, M. H.,
Rick, J.,
Markowitz, J.,
& Hyams, J. S.
(2014). Durability of Maintenance Infliximab Therapy in Children With Crohn's Disease: Are Gender and Concomitant Immunomodulators More Important Than We Thought?. Gastroenterology, 146 (5), S25-S26.
https://corescholar.libraries.wright.edu/pediatrics/617
